Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of macrophage subset and regulator thereof in acute graft versus host disease (aGVHD)

A graft-versus-host, macrophage technology, applied in the field of biomedicine

Active Publication Date: 2021-04-20
PEOPLES HOSPITAL PEKING UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is no report to improve the normalization of the microenvironment of peripheral T cells in aGVHD by regulating the expression of transcription factor KLF4 to regulate the polarization of macrophages, and ultimately improve the function of T cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of macrophage subset and regulator thereof in acute graft versus host disease (aGVHD)
  • Application of macrophage subset and regulator thereof in acute graft versus host disease (aGVHD)
  • Application of macrophage subset and regulator thereof in acute graft versus host disease (aGVHD)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046]Example 1. Application of different macrophage subsets and its regulators in patients with acute transfer

[0047]First, experimental materials

[0048]1. Monoclonal antibody: CD68-FITC (BD Biosciences), CCR2-Alexa Fluor 647 (BDBISCIENCES), CX3CR1-PERCP / CY5.5 (BioLegend), CD163-PE / CY7 (Biolegend), CD14-PEgend CD16-APC / CY7 (BioLegend), IL-6-APC (BD Bioscience), TGF-β-BV421 (BDBiosciences), TNF-ɑ-BV650 (BD Biosciences). CD3-APC / H7 (BD Biosciences), CD8-BV510 (BioLegend), CD25-PE / CY7 (Biolegend), IFN-γ-PERCP / CY5.5 (BioLegend), IL-4-PE (BDBiosciences), IL17A- Fitc (BD Biosciences), Foxp3-Eflour660 (eBioscience).

[0049]2. DAPI solution: Item No. C0065, Beijing So Laobao Company.

[0050]3. Diecetylated low density lipoprotein: DII-ACLDL, Life Technologies.

[0051]4. Balb / c mice in rat BALB / C, Range C57BL / 6 mice (Beijing Virong Lihua Experimental Animal Technology Co., Ltd.).

[0052]5. Recombinant people M-CSF: Catalog # 300-25, US Peprotech.

[0053]6. People CD14 Sorted Magnetic ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a macrophage subset and a regulator thereof in acute graft versus host disease (aGVHD). The application of the substance for detecting the expression quantity of a KLF4 transcription factor or a coded nucleic acid of the KLF4 transcription factor in the macrophage comprises the following steps: preparing a product for detecting the polarization / functional state of the macrophage of an aGVHD patient, diagnosing the aGVHD and / or detecting whether M1 / M2 polarization imbalance occurs in the macrophage or not. It is found that significant decrease of the KLF4 in macrophages is a biomarker of M1 / M2 polarization imbalance function change. The macrophage subset and regulator thereof can be used for detecting the polarization and functional state of the macrophage of the aGVHD patient after hematopoietic stem cell transplantation, and has important clinical significance for disease layered diagnosis and treatment.

Description

Technical field[0001]The present invention relates to the field of biomedical, and more particularly to macrophage subsets and its modulators in an acute transplantive anti-host disease.Background technique[0002]Acute transplantive anti-host disease (AGVHD) is still an important comment of alone hematopoietic stem cell transplantation. AgvHD is often considered immunized by immune-mediated diseases. Specifically, T lymphocytes in the foreign donor grafts, a series of "cytokines storm" motivations launched, greatly enhanced their antigen against the subject The immune response is based on the subject target cells to launch cytotoxic attacks, of which the skin, liver and intestines are the main target objectives, resulting in increased patient-related mortality and increase in medical expenses. Glucocorticoids are current AGVHD's first-line treatment options, but still 40-60% of patients have hormone resistance, and existing second-line therapy effect is poor. Therefore, the in-depth ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/15A61P37/06G01N33/68C12Q1/6883
Inventor 黄晓军孔圆温琦赵红艳
Owner PEOPLES HOSPITAL PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com